Sagimet Biosciences Inc (SGMT)’s stock is trading at $5.27 at the moment marking a rise of 16.85% from the last session close. As of this writing, shares are priced at -74.55% less than their 52-week high of $20.71, and 147.42% over their 52-week low of $2.13. Based on the past 30-day period, the stock price is -30.02% below the high and +38.88% above the low.
SGMT’s price to book ratio for the most recent quarter was 1.15, resulting in an 1.11 price to cash per share for the period.
How does Sagimet Biosciences Inc (SGMT) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 4 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Sagimet Biosciences Inc (SGMT): Earnings History
If we examine Sagimet Biosciences Inc’s recent earnings history, in the last quarter ended on 9/29/2023, it posted adjusted earnings per share of -$0.35, slashing the consensus of -$0.99. In other words, it beat the consensus by $0.64, resulting in a 64.60% surprise. In the 3 months period before the previous quarter which was closed on 9/29/2023, the stock recorded adjusted earnings per share of -$0.35 in contrast with the Outlook of -$0.99. That was a difference of $0.64 and a surprise of 64.60%.
Sagimet Biosciences Inc (NASDAQ: SGMT) Ownership Details
I will give a breakdown of the key shareholders in Sagimet Biosciences Inc (SGMT). Recent figures show that the company’s insiders hold 13.44% of shares. A total of 75 institutional investors hold shares in the company, making 47.26% of its stock and 54.59% of its float.
Dec 30, 2023, it was reported that the Company’s largest institutional holder is NEA Management Company, LLC holding total of 3.85 million shares that make 18.01% of the company’s total number of shares and are currently priced at 20.18 million.
The securities firm FMR, LLC holds 1.92 million shares of SGMT, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 8.99%, and the holding percentage of shares is valued at 10.07 million.
An overview of Sagimet Biosciences Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Sagimet Biosciences Inc (SGMT) traded 1,002,763 shares per day, with a moving average of $5.41 and price change of -1.85. With the moving average of $7.57 and a price change of -1.77, about 2,006,791 shares changed hands on average over the past 50 days. Finally, SGMT’s 100-day average volume is 1,073,797 shares, alongside a moving average of $5.96 and a price change of +1.69.
